HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes
HPV is the major causative agent for cervical cancer. Study on the risk of cervical cancer associated with different hr-HPV genotypes would be useful for disease management and new vaccine strategy. With limited reports available, the present study aimed to investigate the pattern of HPV genotypes c...
Gespeichert in:
| Veröffentlicht in: | PloS one 2017-11, Vol.12 (11), p.e0187844-e0187844 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e0187844 |
|---|---|
| container_issue | 11 |
| container_start_page | e0187844 |
| container_title | PloS one |
| container_volume | 12 |
| creator | Senapati, Rashmirani Nayak, Bhagyalaxmi Kar, Shantanu Kumar Dwibedi, Bhagirathi |
| description | HPV is the major causative agent for cervical cancer. Study on the risk of cervical cancer associated with different hr-HPV genotypes would be useful for disease management and new vaccine strategy. With limited reports available, the present study aimed to investigate the pattern of HPV genotypes coinfections and risk of cervical carcinoma associated with them in Indian population. 15 HPV genotypes were detected by E6/E7 multiplex nested type-specific PCR in the HPV-positive cervical samples of 172 cervical cancer cases and 174 subjects with normal cytology. Association between the genotypes and cervical cancer was estimated by calculating the Odds ratio and 95% confidence interval. Risk of cervical carcinoma was associated with multiple genotypes excluding HPV16 (OR:5.87; 95% CI-1.28-26-29; p = .02), multiple genotypes excluding HPV18 (OR = 2.5; 95% CI = 1.09-6.05; p = .03), multiple genotypes of α9 species(OR = 5.3 95% CI = 1.14-24.03; p = .007), and multiple genotypes of α7 species (OR = 2.5; 95% CI = .49-13.45; p = .2). Genotypes not targeted by quadrivalent vaccine types (OR = 2.94 95% CI = 1.48-5.80; p = .001) conferred 2.94 fold higher risk of cervical carcinoma. Cases those coinfected with phylogenetically related genotypes (OR = 2.29; 95% CI(.69-7.59) p = .17) were at 2.9 fold higher risk of invasive cervical carcinoma than those infected with other genotypes although it is not statistically significant. Whereas phylogenetically unrelated genotypes coinfection is negatively associated with cervical carcinoma (OR = .44 95% CI (.244-.8) p = .007) and it is statistically significant.Genotypes not targeted by 9-valent vaccines (OR = .40; 95% CI = .19-.85; p = .017) associated with lesser risk of cervical carcinoma as compared to other genotypes. Subjects infected with any HPV genotype/genotypes excluding HPV16 in association with HPV 18 (OR = 4.1; 95% CI = 1.81-9.25 P = < .001) were at 4.1 fold higher risk of developing invasive cervical carcinoma.In conclusion, the risk of development of cervical cancer is genotype specific and might be associated with type-specific interactions between the genotypes in multiple infections. |
| doi_str_mv | 10.1371/journal.pone.0187844 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1967041572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A515195293</galeid><doaj_id>oai_doaj_org_article_d63bbc48899742fe862fbadf46f84e74</doaj_id><sourcerecordid>A515195293</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-12e0d239de60cbd9534ed54af332842c737d88f26eee2330942e58c7f3fa3ea3</originalsourceid><addsrcrecordid>eNqNk12LEzEUhgdR3HX1H4gGBNGL1snHZBIvhGVRt7Cw4i57G9LMSTslTbrJTLX_wR9t-rGllb2QXCQkz_uenJOconiNyyGmNf40C3302g0XwcOwxKIWjD0pTrGkZMBJSZ8erE-KFynNyrKigvPnxQmRmGMiqtPiz-WPOzQBH7rVAhIyYdB6C6Zrg09IpxRMqzto0K-2myIDcdka7ZDR0bQ-zPVndLOAjDhkg-kTCh4tpisXsiN0a9StUAS3sdC-QT74wVKbLAbU6TiB9cE-_MvimdUuwavdfFbcfvt6e3E5uLr-Pro4vxoYLkk3wATKhlDZAC_NuJEVZdBUTFtKiWDE1LRuhLCEAwChtJSMQCVMbanVFDQ9K95ubRcuJLWrY1JY8rpkuKpJJkZbogl6phaxneu4UkG3arMR4kTpmPNzoBpOx2PDhJCyZsSC4MSOdWMZt4JBzbLXl120fjyHxoDvonZHpscnvp2qSViqista1DwbfNgZxHDfQ-rUvE0GnNMeQr-9N-OlkOt7v_sHfTy7HTXROYH83iHHNWtTdV7hCsuKSJqp4SNUHg3MW5M_nW3z_pHg45EgMx387ia6T0mNbn7-P3t9d8y-P2CnoF03TcH1mz96DLItaGJIKYLdFxmXat0zD9VQ655Ru57JsjeHD7QXPTQJ_QtkvhSB</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1967041572</pqid></control><display><type>article</type><title>HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Senapati, Rashmirani ; Nayak, Bhagyalaxmi ; Kar, Shantanu Kumar ; Dwibedi, Bhagirathi</creator><contributor>Consolaro, Marcia Edilaine Lopes</contributor><creatorcontrib>Senapati, Rashmirani ; Nayak, Bhagyalaxmi ; Kar, Shantanu Kumar ; Dwibedi, Bhagirathi ; Consolaro, Marcia Edilaine Lopes</creatorcontrib><description>HPV is the major causative agent for cervical cancer. Study on the risk of cervical cancer associated with different hr-HPV genotypes would be useful for disease management and new vaccine strategy. With limited reports available, the present study aimed to investigate the pattern of HPV genotypes coinfections and risk of cervical carcinoma associated with them in Indian population. 15 HPV genotypes were detected by E6/E7 multiplex nested type-specific PCR in the HPV-positive cervical samples of 172 cervical cancer cases and 174 subjects with normal cytology. Association between the genotypes and cervical cancer was estimated by calculating the Odds ratio and 95% confidence interval. Risk of cervical carcinoma was associated with multiple genotypes excluding HPV16 (OR:5.87; 95% CI-1.28-26-29; p = .02), multiple genotypes excluding HPV18 (OR = 2.5; 95% CI = 1.09-6.05; p = .03), multiple genotypes of α9 species(OR = 5.3 95% CI = 1.14-24.03; p = .007), and multiple genotypes of α7 species (OR = 2.5; 95% CI = .49-13.45; p = .2). Genotypes not targeted by quadrivalent vaccine types (OR = 2.94 95% CI = 1.48-5.80; p = .001) conferred 2.94 fold higher risk of cervical carcinoma. Cases those coinfected with phylogenetically related genotypes (OR = 2.29; 95% CI(.69-7.59) p = .17) were at 2.9 fold higher risk of invasive cervical carcinoma than those infected with other genotypes although it is not statistically significant. Whereas phylogenetically unrelated genotypes coinfection is negatively associated with cervical carcinoma (OR = .44 95% CI (.244-.8) p = .007) and it is statistically significant.Genotypes not targeted by 9-valent vaccines (OR = .40; 95% CI = .19-.85; p = .017) associated with lesser risk of cervical carcinoma as compared to other genotypes. Subjects infected with any HPV genotype/genotypes excluding HPV16 in association with HPV 18 (OR = 4.1; 95% CI = 1.81-9.25 P = < .001) were at 4.1 fold higher risk of developing invasive cervical carcinoma.In conclusion, the risk of development of cervical cancer is genotype specific and might be associated with type-specific interactions between the genotypes in multiple infections.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0187844</identifier><identifier>PMID: 29161285</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Biology and life sciences ; Cancer ; Cervical cancer ; Cervical carcinoma ; Cervix ; Complications and side effects ; Computer and Information Sciences ; Confidence intervals ; Cytology ; Deoxyribonucleic acid ; Development and progression ; Disease control ; DNA ; FDA approval ; Genetic aspects ; Genotype ; Genotypes ; Health risks ; Human papillomavirus ; Immunization ; Infections ; Invasiveness ; Laboratories ; Medical research ; Medical screening ; Medicine and Health Sciences ; Multiplexing ; Papillomavirus infections ; Phylogeny ; Physiological aspects ; Risk ; Risk factors ; Sociodemographics ; Statistical analysis ; Statistical methods ; Statistical significance ; Vaccines ; Virology ; Womens health</subject><ispartof>PloS one, 2017-11, Vol.12 (11), p.e0187844-e0187844</ispartof><rights>COPYRIGHT 2017 Public Library of Science</rights><rights>2017 Senapati et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 Senapati et al 2017 Senapati et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-12e0d239de60cbd9534ed54af332842c737d88f26eee2330942e58c7f3fa3ea3</citedby><cites>FETCH-LOGICAL-c692t-12e0d239de60cbd9534ed54af332842c737d88f26eee2330942e58c7f3fa3ea3</cites><orcidid>0000-0002-5318-6836</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697876/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697876/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2095,2914,23846,27903,27904,53770,53772,79347,79348</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29161285$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Consolaro, Marcia Edilaine Lopes</contributor><creatorcontrib>Senapati, Rashmirani</creatorcontrib><creatorcontrib>Nayak, Bhagyalaxmi</creatorcontrib><creatorcontrib>Kar, Shantanu Kumar</creatorcontrib><creatorcontrib>Dwibedi, Bhagirathi</creatorcontrib><title>HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>HPV is the major causative agent for cervical cancer. Study on the risk of cervical cancer associated with different hr-HPV genotypes would be useful for disease management and new vaccine strategy. With limited reports available, the present study aimed to investigate the pattern of HPV genotypes coinfections and risk of cervical carcinoma associated with them in Indian population. 15 HPV genotypes were detected by E6/E7 multiplex nested type-specific PCR in the HPV-positive cervical samples of 172 cervical cancer cases and 174 subjects with normal cytology. Association between the genotypes and cervical cancer was estimated by calculating the Odds ratio and 95% confidence interval. Risk of cervical carcinoma was associated with multiple genotypes excluding HPV16 (OR:5.87; 95% CI-1.28-26-29; p = .02), multiple genotypes excluding HPV18 (OR = 2.5; 95% CI = 1.09-6.05; p = .03), multiple genotypes of α9 species(OR = 5.3 95% CI = 1.14-24.03; p = .007), and multiple genotypes of α7 species (OR = 2.5; 95% CI = .49-13.45; p = .2). Genotypes not targeted by quadrivalent vaccine types (OR = 2.94 95% CI = 1.48-5.80; p = .001) conferred 2.94 fold higher risk of cervical carcinoma. Cases those coinfected with phylogenetically related genotypes (OR = 2.29; 95% CI(.69-7.59) p = .17) were at 2.9 fold higher risk of invasive cervical carcinoma than those infected with other genotypes although it is not statistically significant. Whereas phylogenetically unrelated genotypes coinfection is negatively associated with cervical carcinoma (OR = .44 95% CI (.244-.8) p = .007) and it is statistically significant.Genotypes not targeted by 9-valent vaccines (OR = .40; 95% CI = .19-.85; p = .017) associated with lesser risk of cervical carcinoma as compared to other genotypes. Subjects infected with any HPV genotype/genotypes excluding HPV16 in association with HPV 18 (OR = 4.1; 95% CI = 1.81-9.25 P = < .001) were at 4.1 fold higher risk of developing invasive cervical carcinoma.In conclusion, the risk of development of cervical cancer is genotype specific and might be associated with type-specific interactions between the genotypes in multiple infections.</description><subject>Biology and life sciences</subject><subject>Cancer</subject><subject>Cervical cancer</subject><subject>Cervical carcinoma</subject><subject>Cervix</subject><subject>Complications and side effects</subject><subject>Computer and Information Sciences</subject><subject>Confidence intervals</subject><subject>Cytology</subject><subject>Deoxyribonucleic acid</subject><subject>Development and progression</subject><subject>Disease control</subject><subject>DNA</subject><subject>FDA approval</subject><subject>Genetic aspects</subject><subject>Genotype</subject><subject>Genotypes</subject><subject>Health risks</subject><subject>Human papillomavirus</subject><subject>Immunization</subject><subject>Infections</subject><subject>Invasiveness</subject><subject>Laboratories</subject><subject>Medical research</subject><subject>Medical screening</subject><subject>Medicine and Health Sciences</subject><subject>Multiplexing</subject><subject>Papillomavirus infections</subject><subject>Phylogeny</subject><subject>Physiological aspects</subject><subject>Risk</subject><subject>Risk factors</subject><subject>Sociodemographics</subject><subject>Statistical analysis</subject><subject>Statistical methods</subject><subject>Statistical significance</subject><subject>Vaccines</subject><subject>Virology</subject><subject>Womens health</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk12LEzEUhgdR3HX1H4gGBNGL1snHZBIvhGVRt7Cw4i57G9LMSTslTbrJTLX_wR9t-rGllb2QXCQkz_uenJOconiNyyGmNf40C3302g0XwcOwxKIWjD0pTrGkZMBJSZ8erE-KFynNyrKigvPnxQmRmGMiqtPiz-WPOzQBH7rVAhIyYdB6C6Zrg09IpxRMqzto0K-2myIDcdka7ZDR0bQ-zPVndLOAjDhkg-kTCh4tpisXsiN0a9StUAS3sdC-QT74wVKbLAbU6TiB9cE-_MvimdUuwavdfFbcfvt6e3E5uLr-Pro4vxoYLkk3wATKhlDZAC_NuJEVZdBUTFtKiWDE1LRuhLCEAwChtJSMQCVMbanVFDQ9K95ubRcuJLWrY1JY8rpkuKpJJkZbogl6phaxneu4UkG3arMR4kTpmPNzoBpOx2PDhJCyZsSC4MSOdWMZt4JBzbLXl120fjyHxoDvonZHpscnvp2qSViqista1DwbfNgZxHDfQ-rUvE0GnNMeQr-9N-OlkOt7v_sHfTy7HTXROYH83iHHNWtTdV7hCsuKSJqp4SNUHg3MW5M_nW3z_pHg45EgMx387ia6T0mNbn7-P3t9d8y-P2CnoF03TcH1mz96DLItaGJIKYLdFxmXat0zD9VQ655Ru57JsjeHD7QXPTQJ_QtkvhSB</recordid><startdate>20171121</startdate><enddate>20171121</enddate><creator>Senapati, Rashmirani</creator><creator>Nayak, Bhagyalaxmi</creator><creator>Kar, Shantanu Kumar</creator><creator>Dwibedi, Bhagirathi</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5318-6836</orcidid></search><sort><creationdate>20171121</creationdate><title>HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes</title><author>Senapati, Rashmirani ; Nayak, Bhagyalaxmi ; Kar, Shantanu Kumar ; Dwibedi, Bhagirathi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-12e0d239de60cbd9534ed54af332842c737d88f26eee2330942e58c7f3fa3ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biology and life sciences</topic><topic>Cancer</topic><topic>Cervical cancer</topic><topic>Cervical carcinoma</topic><topic>Cervix</topic><topic>Complications and side effects</topic><topic>Computer and Information Sciences</topic><topic>Confidence intervals</topic><topic>Cytology</topic><topic>Deoxyribonucleic acid</topic><topic>Development and progression</topic><topic>Disease control</topic><topic>DNA</topic><topic>FDA approval</topic><topic>Genetic aspects</topic><topic>Genotype</topic><topic>Genotypes</topic><topic>Health risks</topic><topic>Human papillomavirus</topic><topic>Immunization</topic><topic>Infections</topic><topic>Invasiveness</topic><topic>Laboratories</topic><topic>Medical research</topic><topic>Medical screening</topic><topic>Medicine and Health Sciences</topic><topic>Multiplexing</topic><topic>Papillomavirus infections</topic><topic>Phylogeny</topic><topic>Physiological aspects</topic><topic>Risk</topic><topic>Risk factors</topic><topic>Sociodemographics</topic><topic>Statistical analysis</topic><topic>Statistical methods</topic><topic>Statistical significance</topic><topic>Vaccines</topic><topic>Virology</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Senapati, Rashmirani</creatorcontrib><creatorcontrib>Nayak, Bhagyalaxmi</creatorcontrib><creatorcontrib>Kar, Shantanu Kumar</creatorcontrib><creatorcontrib>Dwibedi, Bhagirathi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Senapati, Rashmirani</au><au>Nayak, Bhagyalaxmi</au><au>Kar, Shantanu Kumar</au><au>Dwibedi, Bhagirathi</au><au>Consolaro, Marcia Edilaine Lopes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2017-11-21</date><risdate>2017</risdate><volume>12</volume><issue>11</issue><spage>e0187844</spage><epage>e0187844</epage><pages>e0187844-e0187844</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>HPV is the major causative agent for cervical cancer. Study on the risk of cervical cancer associated with different hr-HPV genotypes would be useful for disease management and new vaccine strategy. With limited reports available, the present study aimed to investigate the pattern of HPV genotypes coinfections and risk of cervical carcinoma associated with them in Indian population. 15 HPV genotypes were detected by E6/E7 multiplex nested type-specific PCR in the HPV-positive cervical samples of 172 cervical cancer cases and 174 subjects with normal cytology. Association between the genotypes and cervical cancer was estimated by calculating the Odds ratio and 95% confidence interval. Risk of cervical carcinoma was associated with multiple genotypes excluding HPV16 (OR:5.87; 95% CI-1.28-26-29; p = .02), multiple genotypes excluding HPV18 (OR = 2.5; 95% CI = 1.09-6.05; p = .03), multiple genotypes of α9 species(OR = 5.3 95% CI = 1.14-24.03; p = .007), and multiple genotypes of α7 species (OR = 2.5; 95% CI = .49-13.45; p = .2). Genotypes not targeted by quadrivalent vaccine types (OR = 2.94 95% CI = 1.48-5.80; p = .001) conferred 2.94 fold higher risk of cervical carcinoma. Cases those coinfected with phylogenetically related genotypes (OR = 2.29; 95% CI(.69-7.59) p = .17) were at 2.9 fold higher risk of invasive cervical carcinoma than those infected with other genotypes although it is not statistically significant. Whereas phylogenetically unrelated genotypes coinfection is negatively associated with cervical carcinoma (OR = .44 95% CI (.244-.8) p = .007) and it is statistically significant.Genotypes not targeted by 9-valent vaccines (OR = .40; 95% CI = .19-.85; p = .017) associated with lesser risk of cervical carcinoma as compared to other genotypes. Subjects infected with any HPV genotype/genotypes excluding HPV16 in association with HPV 18 (OR = 4.1; 95% CI = 1.81-9.25 P = < .001) were at 4.1 fold higher risk of developing invasive cervical carcinoma.In conclusion, the risk of development of cervical cancer is genotype specific and might be associated with type-specific interactions between the genotypes in multiple infections.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>29161285</pmid><doi>10.1371/journal.pone.0187844</doi><tpages>e0187844</tpages><orcidid>https://orcid.org/0000-0002-5318-6836</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2017-11, Vol.12 (11), p.e0187844-e0187844 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_1967041572 |
| source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry |
| subjects | Biology and life sciences Cancer Cervical cancer Cervical carcinoma Cervix Complications and side effects Computer and Information Sciences Confidence intervals Cytology Deoxyribonucleic acid Development and progression Disease control DNA FDA approval Genetic aspects Genotype Genotypes Health risks Human papillomavirus Immunization Infections Invasiveness Laboratories Medical research Medical screening Medicine and Health Sciences Multiplexing Papillomavirus infections Phylogeny Physiological aspects Risk Risk factors Sociodemographics Statistical analysis Statistical methods Statistical significance Vaccines Virology Womens health |
| title | HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T02%3A09%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HPV%20genotypes%20co-infections%20associated%20with%20cervical%20carcinoma:%20Special%20focus%20on%20phylogenetically%20related%20and%20non-vaccine%20targeted%20genotypes&rft.jtitle=PloS%20one&rft.au=Senapati,%20Rashmirani&rft.date=2017-11-21&rft.volume=12&rft.issue=11&rft.spage=e0187844&rft.epage=e0187844&rft.pages=e0187844-e0187844&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0187844&rft_dat=%3Cgale_plos_%3EA515195293%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1967041572&rft_id=info:pmid/29161285&rft_galeid=A515195293&rft_doaj_id=oai_doaj_org_article_d63bbc48899742fe862fbadf46f84e74&rfr_iscdi=true |